Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Ross

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Journal of the National Cancer Institute|September 1, 1984
Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancerD S Ross, G Steele, J Madara, et al.
Journal of the National Cancer Institute|May 1, 1984
Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasiaS J Lahey, G Steele, R Berkowitz, et al.
Journal of Surgical Oncology|August 1, 1984
The effect of 1,2-dimethylhydrazine (DMH) carcinogenesis on peripheral T cell subsets in the Wistar Furth ratD S Ross, G Steele, M L Rodrick, et al.
Cancer|March 15, 1984
Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasiaS J Lahey, G Steele, M L Rodrick, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1994
Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)C A Meier, L E Braverman, S A Ebner, et al.
Journal of the National Cancer Institute|June 1, 1983
Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF ratsM L Rodrick, G Steele, D S Ross, et al.
The New England Journal of Medicine|September 26, 1997
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinomaP W Ladenson, L E Braverman, E L Mazzaferri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2020
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patientsD S Ross, B Liu, A M Schram, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 1998
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative RegistryD S Cooper, B Specker, M Ho, et al.
Cancer|September 10, 1998
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry GroupS I Sherman, J D Brierley, M Sperling, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Journal of the National Cancer Institute|September 1, 1984
Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancerD S Ross, G Steele, J Madara, et al.
Journal of the National Cancer Institute|May 1, 1984
Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasiaS J Lahey, G Steele, R Berkowitz, et al.
Journal of Surgical Oncology|August 1, 1984
The effect of 1,2-dimethylhydrazine (DMH) carcinogenesis on peripheral T cell subsets in the Wistar Furth ratD S Ross, G Steele, M L Rodrick, et al.
Cancer|March 15, 1984
Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasiaS J Lahey, G Steele, M L Rodrick, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1994
Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)C A Meier, L E Braverman, S A Ebner, et al.
Journal of the National Cancer Institute|June 1, 1983
Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF ratsM L Rodrick, G Steele, D S Ross, et al.
The New England Journal of Medicine|September 26, 1997
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinomaP W Ladenson, L E Braverman, E L Mazzaferri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2020
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patientsD S Ross, B Liu, A M Schram, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 1998
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative RegistryD S Cooper, B Specker, M Ho, et al.
Cancer|September 10, 1998
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry GroupS I Sherman, J D Brierley, M Sperling, et al.
Pageof 14